Abstract
Introduction Though there has been an increase in use of long acting and permanent methods of contraception (LAPMs) globally over the last decade, the rates of unintended pregnancy still remain high. In Sub-Saharan African and especially in Kenya, while there has been increase in the uptake of LAPMs over the past years, there are limited recently available evidences on the real magnitude, recent trends and factors associated to demand for LAPMs among sexually active women in the reproductive age.
Methods In this study, we used data from seven survey rounds (2014 to 2018) of a nationally representative Performance Monitoring and Accountability 2020 (PMA2020) household and female survey. PMA2020 survey is based on a multi-stage cluster sample design to draw a probability sample of households and eligible females. In this analysis, both descriptive and inferential statistics were used for data analysis and interpretations. Statistical significance was considered for p-values <0.05. STATA 16.0 software was used for all analyses.
Results Among the 17,455 sexually active women in the reproductive age included in this study, 83.1% had demand for LAPMs. The total demand for LAPMs significantly decreased from 85.0% in 2014 to 81.0% in 2018. Age of the respondents, marital status, parity, rural/urban residence, county of residence and access to Family Planning/contraceptives information via media in the last 12 months were significantly associated with demand for LAPMs.
Conclusion The total demand for LAPMs among sexually active women in Kenya is high, with the bigger share of the demand being unmet. Targeted programs to satisfy the existing demand of LAPMs and address the issue of unmet need for LAPMs should be put in place to ensure no woman is left behind. Similarly, programmers/advocates should utilize the locally available channels e.g. the media to generate new demand and overturn the decreasing demand for LAPMs.
STRENGTHS AND LIMITATIONS OF THIS STUDY
The nationally representative Performance Monitoring and Accountability 2020 (PMA2020) surveys are modelled on the insight from Demographic and Health Survey (DHS).
PMA2020 uses standardized questionnaires (with questions extracted from DHS which have been validated and are extensively used in FP programs) to gather data about households and individual females that are comparable across program countries and consistent with existing national surveys.
There are strengths to the PMA2020 survey which include inclusion of a large sample of women, use of data collectors without medical training and real-time data collection with sufficient controls for quality assurance.
There are some limitations to consider when interpreting the data. Some outputs of this study utilized pooled data from seven-rounds of PMA2020 survey.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The data collection funding was provided by the Bill & Melinda Gates Foundation. No additional funding was sought to complete this article. The funding body had no role in the design of the study, data collection, analysis, and interpretation of data and in writing the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical clearance for conducting PMA2020 study was obtained from the Kenyatta National Hospital/University of Nairobi ethical review committee (REF: P15/01/2014 and P801/09/2019), National Commission for Science, Technology and Innovation (REF: NACOSTI/P/14/0813/1676 and NACOSTI/P/19/2754).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
PMA2020 data are accessible on request through the project website upon approval by PMA2020's coordinating center at JHU in Baltimore. However, data used for this analysis can be made available by the research team to researchers who meet the criteria for access to data